年轻早期低级别子宫内膜癌患者保留卵巢后的复发、死亡及第二原发恶性肿瘤
这项多中心回顾性研究纳入美国队列1196例和日本队列495例50岁以下、I期1-2级子宫内膜样癌且接受子宫切除术的患者,比较保留卵巢与卵巢切除术的肿瘤学结局。美国队列中保留卵巢率从5.4%升至16.4%(P=0.020),日本队列无变化(6.3-8.7%,P=0.787);美国队列保留卵巢与无病生存、总生存及第二原发恶性肿瘤均无显著关联,日本队列保留卵巢与无病生存降低及第二原发恶性肿瘤(尤其卵巢癌)风险升高相关,但均与总生存无显著关联。
要点
- 美国队列保留卵巢率从5.4%升至16.4%(P=0.020),日本队列无变化(6.3-8.7%,P=0.787)。
- 美国队列保留卵巢与无病生存(HR 0.829)、总生存(P=0.981)及第二原发恶性肿瘤(HR 1.787)均无显著关联。
- 日本队列保留卵巢与无病生存降低(HR 5.214)及第二原发恶性肿瘤风险升高(HR 7.119)相关,但与总生存无显著关联(P=0.987)。
核心结论
- 研究提示年轻早期低级别子宫内膜癌患者保留卵巢的采纳情况因人群而异。
- 在某些人群中,保留卵巢可能与卵巢复发或第二原发卵巢癌风险增加相关,但未对总生存产生负面影响。
研究设计与样本
- 多中心回顾性研究,纳入2000年至2014年接受初次子宫切除术的50岁以下、I期1-2级子宫内膜样癌患者,美国队列n=1196,日本队列n=495。
- 根据保留卵巢与卵巢切除术分组,评估复发模式、生存及第二原发恶性肿瘤。
主要发现
- 美国队列保留卵巢率从5.4%升至16.4%(P=0.020),日本队列为6.3-8.7%(P=0.787)。
- 美国队列保留卵巢与无病生存(HR 0.829,95%CI 0.188-3.663,P=0.805)、总生存(HR未估计,P=0.981)及第二原发恶性肿瘤(HR 1.787,95%CI 0.603-5.295,P=0.295)均无显著关联。
- 日本队列保留卵巢与无病生存降低(HR 5.214,95%CI 1.557-17.464,P=0.007)及第二原发恶性肿瘤风险升高(HR 7.119,95%CI 1.349-37.554,P=0.021)相关,尤其卵巢癌,但与总生存无显著关联(HR未估计,P=0.987)。
- 卵巢复发或第二原发卵巢癌的中位发生时间为5.9年,所有病例均获挽救。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the association between ovarian conservation and oncologic outcome in surgically-treated young women with early-stage, low-grade endometrial cancer. METHODS: This multicenter retrospective study examined women aged <50 with stage I grade 1-2 endometrioid endometrial cancer who underwent primary surgery with hysterectomy from 2000 to 2014 (US cohort n = 1196, and Japan cohort n = 495). Recurrence patterns, survival, and the presence of a metachronous secondary malignancy were assessed based on ovarian conservation versus oophorectomy. RESULTS: During the study period, the ovarian conservation rate significantly increased in the US cohort from 5.4% to 16.4% (P = 0.020) whereas the rate was unchanged in the Japan cohort (6.3-8.7%, P = 0.787). In the US cohort, ovarian conservation was not associated with disease-free survival (hazard ratio [HR] 0.829, 95% confidence interval [CI] 0.188-3.663, P = 0.805), overall survival (HR not estimated, P = 0.981), or metachronous secondary malignancy (HR 1.787, 95% CI 0.603-5.295, P = 0.295). In the Japan cohort, ovarian conservation was associated with decreased disease-free survival (HR 5.214, 95% CI 1.557-17.464, P = 0.007) and an increased risk of a metachronous secondary malignancy, particularly ovarian cancer (HR 7.119, 95% CI 1.349-37.554, P = 0.021), but was not associated with overall survival (HR not estimated, P = 0.987). Ovarian recurrence or metachronous secondary ovarian cancer occurred after a median time of 5.9 years, and all cases were salvaged. CONCLUSION: Our study suggests that adoption of ovarian conservation in young women with early-stage low-grade endometrial cancer varies by population. Ovarian conservation for young women with early-stage, low-grade endometrial cancer may be potentially associated with increased risks of ovarian recurrence or metachronous secondary ovarian cancer in certain populations; nevertheless, ovarian conservation did not negatively impact overall survival.
引用
- Matsuo K, Cripe JC, Kurnit KC, et al. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer. Gynecol Oncol. 2019. PMID: 31427143. doi:10.1016/j.ygyno.2019.08.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。